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Abstract  (15 lines) 
 
Background & Objectives: To explore variation in red blood cell transfusion rates between hospitals, and 
the extent to which this can be explained. A secondary objective was to assess whether hospital 
transfusion rates are associated with maternal morbidity. Materials & Methods: Linked hospital 
discharge and birth data were used to identify births (N=279,145) in hospitals with at least 10 deliveries 
per annum between 2008-2010 in New South Wales, Australia. To investigate transfusion rates, a series 
of random effects multilevel logistic regression models were fitted, progressively adjusting for maternal, 
obstetric and hospital factors. Correlations between hospital transfusion and maternal, neonatal 
morbidity and readmission rates were assessed. Results: Overall, the transfusion rate was 1.4% (hospital 
range 0.6 to 2.9) across 89 hospitals. Adjusting for maternal casemix, reduced the variation between 
hospitals by 26%. Adjustment for obstetric interventions further reduced variation by 8% and a further 
39% after adjustment for hospital type. At a hospital level, high transfusion rates were moderately 
correlated with maternal morbidity (0.56, p=0.01) and low Apgar scores (0.54, p=0.002), but not with 
readmission rates (0.18, p=0.28). Conclusion: Both casemix and practice differences contributed to the 
variation in transfusion rates between hospitals. The relationship between outcomes and transfusion 
rates was variable, however low transfusion rates were not associated with worse outcomes. 
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Background 
In recent years there has been growing consideration of the need to limit the use of blood transfusions. 
Although allogeneic blood transfusion in Australia is extremely safe from an infection transmitted 
disease perspective, it is a limited and expensive resource that has significant potential non-infectious 
hazards. [1] There is now an increased emphasis on patient blood management, an individualized 
approach which aims to manage patients in such a way as to reduce the need for transfusion and 
therefore avoid unnecessary exposure to blood and blood products. [1, 2]  This emphasis has been 
reflected in blood usage guidelines and standards proposed internationally.[3, 4] The Australian National 
Blood Authority have developed national standards on use of blood components and products  to 
“ensure that the patients who receive blood and blood products do so appropriately and safely.” [5] 
Benchmarking studies have recognized that in disciplines where there is wide variation in transfusion 
rates between hospitals, there is the potential for transfusion rates to be reduced, without affecting 
patient outcomes.[6]  
 
Variation in blood transfusion rates between hospitals has been studied for over twenty years. In 1991, 
Goodnough published an influential study on transfusion rates in coronary artery bypass graft (CABG) 
surgery, showing that large variation in transfusion rates between hospitals persisted despite 
adjustment for some casemix factors.[7] These findings have been replicated in areas such as cardiac 
surgery, orthopaedics and other elective surgery, with some attempts to identify possible factors 
accounting for the observed variation.[8-10] The discipline of obstetrics has been largely absent from 
these studies,[6] and current national guidelines on obstetric blood component use, although proposed, 
do not exist. [11] Blood transfusion in obstetric practice differs from other fields, in that the majority of 
transfusions are in response to unexpected obstetric haemorrhage occurring in otherwise healthy 
women.[12, 13] Variation in clinical practice has been demonstrated for other obstetric interventions 
such as caesarean section rates and induction of labour [14, 15] so one may reasonably expect that 
blood transfusion rates will differ between hospitals. 
Internationally obstetric transfusion rates range from 0.1-1.9%, [16, 17] and have been increasing in 
recent years.[13, 18] The most common indication for transfusion in the obstetric setting is postpartum 
haemorrhage (PPH; excessive bleeding post childbirth), but it can also be used to treat anaemia from 
other causes,[19, 20] and in patients with inherited bleeding disorders.[21] Quality evidence to inform 
clinical practice around transfusion in obstetrics is limited.[21] It is clear that in cases of massive 
haemorrhage, failure to transfuse a patient could cause harm, as could poor management of bleeding 
disorders, however the benefits of transfusion for anaemia in haemodynamically stable patients are less 
clear.[2] 
This study aims to 1) explore variation in transfusion rates between hospitals, and to what extent this 
can be explained by casemix, interventions and hospital level factors; and 2) to determine whether high 
or low hospital transfusion rates are associated with higher rates of maternal morbidity. 
Methods 
The study population for this research consisted of all women giving birth in NSW hospitals from 2008-
2010 to an infant(s) of at least 20 weeks gestation. NSW is the largest state in Australia, with over 
90,000 births per year. Hospitals, and women giving birth in those hospitals, were excluded if there were 
fewer than 10 births per year across the study period. Women with missing covariate data were also 
excluded. Data on maternal characteristics, pregnancy, labour and birth were obtained from the 
Perinatal Data Collection (‘birth data’), a population based collection of data on all births of at least 400g 
birthweight or 20 weeks gestation. Data on maternal risk factors, procedures and fact of transfusion 
were obtained from the Admitted Patients Data Collection (‘hospital data’), a census of all public and 
private hospital inpatient separations in NSW coded to the Australian Classification of Health 
Interventions[22] and International Classification of Diseases- Australian Modification (ICD-10-AM)[23]. 
Infant hospital data were also linked to the birth data to provide information on neonatal readmission 
within 6 weeks, diagnoses and procedures. NSW Centre for Health Record Linkage performed 
probabilistic data linkage between the two data sets, with linkage proportions over 98%. Only the 
deidentified data were provided to researchers. 
Transfusion of red blood cells (RBC) during the birth admission included any record of transfusion of 
packed cells or whole blood in the procedure codes for the maternal hospital admission. For the 
purposes of this study, the transfusion rate refers to transfusion of RBC either alone or in conjunction 
with other blood products. A range of factors that could potentially affect the hospital transfusion rate 
were considered, and categorized according to whether they were maternal casemix factors, obstetric 
interventions at an individual level, or hospital level characteristics or intervention rates (Appendix 1).  
Maternal conditions associated with a high risk of bleeding were identified from the hospital records. 
These were placenta praevia, antepartum haemorrhage (APH; including placental abruption), and 
bleeding/platelet disorder (including thalassaemia, haemolytic and aplastic anaemias, and coagulation 
defects (ICD10-AM codes D56-D61,D63-D64,D66-D69,D72-D77)). Other maternal and pregnancy factors 
identified from the hospital data, birth data or both (depending on reporting) were maternal age (under 
25 years, 25-34 years, 35 year or older), maternal country of birth (Australia/other), parity, maternal 
smoking, previous caesarean, hypertension (chronic or pregnancy), diabetes (gestational or other), 
multiple pregnancy, gestational age (very preterm (<33 weeks), preterm (33-36 weeks), term (≥37 
weeks)), large for gestational age infant (>90th centile). Socioeconomic status was measured using the 
Socioeconomic Indicator For Areas index of relative disadvantage.[24] In Australia, some maternity 
patients are privately insured or private payers, and can receive care as a private patient in a public or 
private hospital; ‘private patient’ is used to refer to either situation. A woman was considered to be at 
low risk antenatally for transfusion if she was delivering a singleton infant at term, and did not have a 
condition placing her at high risk of bleeding (APH, placenta praevia, bleeding/platelet disorder) or other 
medical condition (diabetes, hypertension). Interventions were obtained from the birth data (induction, 
instrumental delivery, caesarean section (intrapartum/prelabour), regional analgesia, augmentation), or 
both hospital and birth data (episiotomy).  
In NSW, some private hospitals are located in close proximity to or on the same grounds as a public 
hospital, and in these cases there is sharing of staff between the two hospitals. In this case, the private 
hospital is defined as case as a ‘colocated private’ hospital, and the public hospital as a ‘colocated public’ 
hospital. Hospitals were also coded as primary, secondary or non obstetric training hospitals (where 
primary refers to hospitals co-ordinating registrar training, and secondary to hospitals where registrars 
may be sent on placement). Hospital intervention rates (caesarean section, induction, instrumental 
delivery, regional analgesia), private insurance and preterm birth rates amongst all patients were also 
considered. As information on the anaesthetic cover for each hospital was unavailable, the proportion of 
caesarean sections performed under general anaesthesia (GA) was used as a proxy (with a higher 
proportion of caesarean sections under GA indicating a lower level of specialist obstetric anaesthetic 
cover).  
Maternal morbidity was assessed using a validated composite indictor which included obstetric 
embolism, organ failure, mechanical ventilation, hysterectomy, shock and other diagnoses and 
procedures associated with severe morbidity.[25]  While the published indicator includes transfusion of 
blood and blood products, these were removed from the indicator for the purposes of this study.  
Readmission within 6 weeks of the birth and 5 minute Apgar <7 (as a marker of neonatal morbidity) 
were also considered. Only reliably reported, validated variables were used in analysis.[26-29]  
To explore the degree of variation in RBC transfusion rates between hospitals, a series of random effects 
multilevel logistic regression models were fitted, progressively adjusting for maternal, intervention and 
hospital factors.[30] Maternal factors significant in univariable analysis were included in the maternal 
factors model, and non-significant variables progressively removed until only variables significant at 
alpha=0.05 remained. All significant variables in the maternal model were retained for the intervention 
model, and intervention variables were removed until only significant variables remained. Hospital 
factors were added into the intervention model one at a time, and the variable which most reduced the 
between hospital variation was retained. This process was repeated to identify further significant 
hospital factors. Factors considered at each stage are listed in Appendix 1. A random effects model was 
used so to shrink hospitals with the greatest variability towards the overall transfusion rate. The hospital 
specific odds of transfusion were converted to risk adjusted transfusion rates. The variability between 
hospitals was quantified using the variance of the random effect, and the percentage change between 
models used to show reduction in variation after adjustment. A sensitivity analysis was performed 
considering transfusions amongst low risk women. All models were fitted in SAS V9.3. 
In order to assess the appropriateness of high and low transfusion practice, the correlation between 
hospital adjusted rates of blood transfusion and maternal casemix adjusted rates of each of maternal 
morbidity, readmission and neonatal Apgar <7 at 5 minutes were calculated using  multivariate 
multilevel models, jointly considering the morbidity and transfusion as outcomes. 
Ethical approval for this study was obtained from the NSW Population and Health Services Research 
Ethics Committee. 
Results  
Between 2008 and 2010 there were 281,543 births across 117 hospitals. After excluding births in 
hospitals of less than 10 births per year, there were 280,245 births across 89 hospitals. A further 1100 
women with missing values for explanatory variables were excluded, leaving 279,145(99%) births for 
analysis.   
Overall, the RBC transfusion rate was 1.4% (N=3914). Women receiving  transfusions were more likely to 
be primiparous (51.7% vs 42.4%), undergoing an instrumental delivery (21.2% vs 11.6%), having a large 
for gestational age (16.2% vs 10.9%) or preterm infant (14.9% vs 6.4%), twins or higher order birth (4.4% 
vs 1.5%), or have a bleeding or platelet disorder (9.0% vs 0.7%); and were less likely to be delivering 
vaginally (41.9% vs 58.6%), or private patients (22.7% vs 34.4%) (Table 1). 
Unadjusted hospital transfusion rates ranged from 0.6% to 2.9%. Adjusting for the differing casemix 
(maternal factors) between hospitals reduced the variation by 26.5% (Table 2), with adjusted rates 
ranging from 0.6% to 2.8%. After adjusting for intervention factors, the variation was further reduced by 
8.0% (range 0.7% to 2.5%), and after adjusting for hospital factors this reduced a further 38.6% (range 
1.1%, 2.0%) (Figure 1).   
 
When potential hospital level factors were included individually in the interventions model, colocation, 
the proportion of private patients, the rates of caesarean section, instrumental delivery, episiotomy, 
analgesia, caesarean section under GA and augmentation, the average socioeconomic status for women 
in the hospital, and location (metropolitan/regional) demonstrated a statistically significant association 
with the hospital transfusion rate and reduced the variation between hospitals. Colocation most 
reduced the variation between hospitals and no other factor retained significance in a model including 
colocation. Patients at a private hospital (whether colocated or not) had lower odds of receiving a 
transfusion, with patients at a private hospital colocated with a public hospital being at the lowest risk 
(OR 0.47 95%CI (0.37,0.59)) compared with non-colocated public hospitals. Overall, 73.0% of the 
hospital variation in the crude model could be explained by the combination of casemix, intervention 
and hospital factors (Table 2). 
 
Compared with a hospital in the middle quintile, the adjusted odds of transfusion in a high transfusing 
hospital were 1.6 (95% CI 1.4,1.7) and in a low transfusing hospital 0.4 (95% CI 0.4,0.5). 
A sensitivity analysis amongst women at low antenatal risk for postpartum haemorrhage at term 
showed a similar reduction in variability after adjusting for casemix (39.6%), a slight reduction after 
adjustment for intervention (1.5%) and a further 24.6% reduction having adjusted for hospital factors. 
Again, colocation of facilities most reduced the variation at a hospital level. Casemix, intervention and 
hospital factors explained 65.7% of the overall variation between hospitals. 
Maternal morbidity and readmission rates were higher among women receiving a transfusion (maternal 
morbidity: 13.4% vs 0.6%; readmission: 6.3% vs 2.6%). The proportion of infants having a low Apgar 
score was also higher for women receiving a transfusion (6.9% vs 1.8%) (Table 3). At a hospital level, 
maternal morbidity was moderately correlated with transfusion rates (0.59, p=0.01), with higher 
transfusing hospitals having higher rates of maternal morbidity. Transfusion rates were not significantly 
correlated with readmission rates (0.18, p=0.29), or infants with low Apgar scores (0.39, p=0.08) (Figure 
2).  
 
Discussion 
Overall, 1.4% of birth admissions between 2008 and 2010 involved a RBC transfusion. Considerable 
variation in obstetric transfusion rates was evident between hospitals in NSW, with the highest 
transfusing hospital having four times the transfusing rate of the lowest transfusing hospital. Models 
that adjusted for patient, intervention and hospital factors demonstrated some reduction in variation. 
Adjustment for casemix (factors not amenable to change) explained 26% of variation, obstetric 
interventions explained a further 8% of variation, and hospital factors a further 39%, reducing the 
unexplained variation compared with the unadjusted rates by 73%. A similar pattern was seen when the 
analysis was limited to women at low antenatal risk for postpartum haemorrhage. Despite the range of 
transfusion rates across hospitals, there was little evidence of a difference in maternal outcomes with a 
changing transfusion rate. 
The transfusion rates observed in NSW are at the higher end of the range of transfusion rates observed 
elsewhere. While Danish and Finnish studies have reported obstetric transfusion rates of around 2%,[16, 
31] rates in the USA were 1.0% in 2009, [18 ] and in Ireland increased from 0.05% to 1.29% between 
1999 and 2009.[17] Although differences in the maternal population may partially explain the difference 
in rates between countries, such variation suggests the potential to reduce transfusion rates without 
associated negative outcomes.  
Casemix factors unsurprisingly explained some of the variation in transfusion rates that was seen 
between hospitals. Consistent with other studies, the greatest maternal risk factors for transfusion 
during the birth admission were bleeding/platelet disorders, placenta praevia, APH and multiple 
births.[19, 31-33] Although these conditions are rare, they are potentially treated in tertiary hospitals, 
resulting in appropriately higher transfusion rates in tertiary hospitals. Because a hospital’s casemix is 
largely not amenable to change, it is important to take this into account before comparing hospital 
rates.  
Adjustment for intervention or management factors over which the clinician has some control 
contributed little to explaining remaining variation between hospitals (8.0%). Although intervention 
factors contribute to the risk of transfusion,[17, 19, 31] the practices associated with these interventions 
vary significantly between hospitals.[14, 15] Such unmeasured differences in clinical practice mean that 
taking into account the management of women of similar risk profiles in different settings did not 
contribute greatly to our understanding of variation between hospitals. 
Hospital level factors explained a considerable proportion of the remaining variation, suggesting that 
there are clinical practice and hospital culture factors affecting transfusion rates. Type of hospital (in 
particular public versus private) was associated with reduction in variation in transfusion rates. It is not 
clear if this is related to patients being appropriately risk managed, or if there are some issues in access 
to blood products that may explain this finding. Sharing of consultants between co-located private and 
public hospitals may be a factor, with consultants preferentially booking women with higher risk of 
bleeding at the public hospital where there are 24 hour onsite facilities. Guidelines on the management 
of women at high risk of bleeding involve consideration of an appropriate place of birth, with ready 
access to blood and blood products,[21, 34] such as a larger urban hospital or tertiary centre. Thus, it is 
possible that some reduction in variability due to hospital type is related to private hospitals having a 
lower risk subset of women,[35] which was not fully accounted for in the adjustment. It is also possible 
however that this represents a true, unmeasured, difference in practice between public and private 
hospital clinicians. Access to blood and blood products may vary by hospital type. Blood and blood 
products are provided free of charge to private hospitals,[36] so it is unlikely that financial 
considerations are influencing blood use, however practical issues such as low on-site stores and blood 
bank facilities may be responsible for differing access.   
The relationship between hospital transfusion rates and maternal outcomes was variable. At a hospital 
level, there was moderate correlation between transfusion rates and maternal morbidity, however 
there was no correlation with readmission rates or neonatal morbidity. Readmission rates are 
potentially less robust markers of outcome that may reflect differing admission practices and access to 
local care rather than serious adverse outcome. The correlation between transfusion and maternal 
morbidity may suggest that either there is some aspect of practice which contributes to jointly higher 
morbidity and transfusions, or that there are aspects of casemix leading to both higher morbidity and 
transfusion rates that are not accounted for completely in modelling. Evidence on improved outcomes 
associated with either a restrictive or liberal transfusing strategy in obstetric practice is limited.[37] A 
recent Cochrane review on restrictive versus liberal transfusion thresholds in any setting supported the 
use of a restrictive transfusion thresholds,[38] however none of the studies included obstetrics patients. 
In the context of obstetric transfusions, the majority of which are in response to unpredictable obstetric 
haemorrhage, one cannot assume that a low transfusing hospital represents best practice. However, 
high transfusing hospitals may also not represent optimal care, with evidence of overtransfused 
obstetrics patients noted in hospital audit studies,[37, 39] and studies of transfusion to treat anaemia in 
women postnatally finding no clear benefit of this practice.[20, 40] Thus it is important for research 
exploring variation in transfusion rates to concurrently take into account outcomes, to ensure that 
efforts to reduce blood use and variation do not cause harm.  
The extent of variation observed in this study after adjusting for casemix is considerable, with an over 
fourfold difference in transfusion rate between the lowest and highest transfusion hospital. The 
variation seen here is somewhat lower than observed in other specialties. Bennett-Guerrero et al report 
an almost eightfold difference in transfusion rates for coronary artery bypass graft surgery,[8] and for 
non-cardiac surgery Qian et al found upwards of thirty-fold differences in transfusion rates.[10] The 
lower transfusion rate in obstetric practice compared with other specialties may be partially responsible 
for the lower variation. Additionally, as most obstetric transfusions are given in the context of 
haemorrhage, for which transfusion is often recommended,[12] there may be less room for variable 
practices. Karkouti et al found lower variation between hospitals of large volume transfusion rates and 
rates of transfusion for excessive blood loss compared with any transfusion.[9] 
The strengths of this study lie in its use of reliably reported, population data to identify variation in 
blood transfusion rates between hospitals. Use of multilevel models allowed for differences in casemix 
to be taken into account, as well as similarities in births within hospitals. This then allowed for 
identification of potentially modifiable clinical practice factors which could be targeted to reduce 
variation in transfusion rates between hospitals. This study also potentially highlights target hospitals for 
audit studies, where clinical decision-making aspects of care that are not captured in these routinely 
collected data have been identified. In this study only fact of transfusion was available, rather than the 
quantity transfused. It has been suggested elsewhere that there is less variation between hospitals in 
large volume transfusion rates,[9] as these represent severe cases with clearer transfusion need. An 
additional limitation is that casemix factors not adjusted for at an individual level would appear as 
between hospital variation, however a wide range of risk factors were considered so the effect of this 
would be small. Because of the reliance on administrative data, it is sometimes unclear whether poor 
outcomes are the result of transfusion, or the transfusion was a response to a developing poor outcome.  
Differences in obstetric transfusion rates were evident in NSW and these differences persisted after 
adjustment for differing casemix between hospitals. This suggests the presence of clinical practice 
factors which influence blood use, and the presence of potential over- or under-transfusion in some 
hospitals. Investigation of these factors could inform practice guidelines which could result in decreased 
variation in transfusion rates, without compromising quality of care. 
 
Acknowledgements:  
Jillian Patterson analyzed the data and all other authors were involved in the interpretation of the data 
and provided advice on improvements and further analyses. Jillian Patterson, Christine Roberts and Jane 
Ford drafted this manuscript. James Isbister, David Irving, Michael Nicholl and Jonathan Morris critically 
reviewed the manuscript and provided guidance on clinical and health service interpretations. This work 
was supported by a Partnership Grant from the Australian National Health and Medical Research Council 
NHMRC (#1027262), the Australian Red Cross and the NSW Clinical Excellence Commission. Christine 
Roberts is supported by a NHMRC Senior Research Fellowship (#1021025). Jane Ford is supported by an 
ARC Future Fellowship (#120100069). We thank the NSW Ministry of Health for access to the population 
health data and the NSW Centre for Health Record Linkage for linking the data sets. 
  
References 
1 Spahn DR, Moch H, Hofmann A, et al.: Patient blood management: the pragmatic solution for 
the problems with blood transfusions. Anesthesiology. 2008;109: 951-3. 
2 Isbister JP: The three-pillar matrix of patient blood management--an overview. Best Pract Res 
Clin Anaesthesiol. 2013;27: 69-84. 
3 Carson JL, Grossman BJ, Kleinman S, et al.: Red Blood Cell Transfusion: A Clinical Practice 
Guideline From the AABB*. Ann Intern Med. 2012;157: 49-58. 
4 World Health Organization (WHO): 63rd World Health Assembly. Availability, safety and quality 
of blood products. 2010. 
5 Australian Commission on Safety and Quality in Health Care (ACSQHC): National Safety and 
Quality Health Service Standards. Sydney, 2011. 
6 Murphy MF, Stanworth SJ, Yazer M: Transfusion practice and safety: current status and 
possibilities for improvement. Vox Sang. 2011;100: 46-59. 
7 Goodnough LT, Johnston MF, Toy PT: The variability of transfusion practice in coronary artery 
bypass surgery. Transfusion Medicine Academic Award Group. JAMA. 1991;265: 86-90. 
8 Bennett-Guerrero E, Zhao Y, O'Brien SM, et al.: Variation in use of blood transfusion in coronary 
artery bypass graft surgery. JAMA. 2010;304: 1568-75. 
9 Karkouti K, Wijeysundera DN, Beattie WS, et al.: Variability and predictability of large-volume 
red blood cell transfusion in cardiac surgery: a multicenter study. Transfusion (Paris). 2007;47: 
2081-8. 
10 Qian F, Osler TM, Eaton MP, et al.: Variation of blood transfusion in patients undergoing major 
noncardiac surgery. Ann Surg. 2013;257: 266-78. 
11 National Blood Authority A: Patient Blood Management Guidelines.  (Last accessed 17/12/2013 
2013). 
12 McLintock C, James AH: Obstetric hemorrhage. J Thromb Haemost. 2011;9: 1441-51. 
13 Patterson JA, Roberts CL, Bowen JR, et al.: Blood transfusion during pregnancy, birth and the 
postnatal period. Obstet Gynecol. 2014;123: 126-33. 
14 Lutomski JE, Morrison JJ, Lydon-Rochelle MT: Regional variation in obstetrical intervention for 
hospital birth in the Republic of Ireland, 2005–2009. BMC pregnancy and childbirth. 2012;12: 
123. 
15 Glantz JC: Obstetric variation, intervention, and outcomes: doing more but accomplishing less. 
Birth. 2012;39: 286-90. 
16 Holm C, Langhoff-Roos J, Petersen KB, et al.: Severe postpartum haemorrhage and mode of 
delivery: a retrospective cohort study. BJOG. 2012;119: 596-604. 
17 Lutomski JE, Greene RA, Byrne BM: Severe maternal morbidity during childbirth hospitalisation: 
a comparative analysis between the Republic of Ireland and Australia. Eur J Obstet Gynecol 
Reprod Biol. 2012;163: 148-53. 
18 Callaghan WM, Creanga AA, Kuklina EV: Severe maternal morbidity among delivery and 
postpartum hospitalizations in the United States. Obstet Gynecol. 2012;120: 1029-36. 
19 Jou HJ, Hung HW, Yan YH, et al.: Risk factors for blood transfusion in singleton pregnancy 
deliveries in Taiwan. Int J Gynaecol Obstet. 2012;117: 124-7. 
20 Palo R, Ahonen J, Salo H, et al.: Transfusion of red blood cells: no impact on length of hospital 
stay in moderately anaemic parturients. Acta Anaesthesiol Scand. 2007;51: 565-9. 
21 Royal College of Obstetricians and Gynaecologists: Blood transfusion in obstetrics. Green-top 
Guideline No. 47. Royal College of Obstetricians and Gynaecologists,. 2007. 
22 National Centre for Classification in Health: Australian classification of health interventions. 
Sydney: National Centre for Classification in Health; 2006. 
23 National Centre for Classification in Health: Tabular list of diseases ICD 10 AM. Sydney: National 
Centre for Classification in Health; 2006. 
24 Pink B: Information Paper: An introduction to Socio-Economic Indexes for Areas (SEIFA) 2006. 
Australian Bureau of Statistics, 2008. 
25 Roberts CL, Cameron CA, Bell JC, et al.: Measuring maternal morbidity in routinely collected 
health data: development and validation of a maternal morbidity outcome indicator. Med Care. 
2008;46: 786-94. 
26 Hadfield RM, Lain SJ, Cameron CA, et al.: The prevalence of maternal medical conditions during 
pregnancy and a validation of their reporting in hospital discharge data. Aust N Z J Obstet 
Gynaecol. 2008;48: 78-82. 
27 Lain SJ, Roberts CL, Hadfield RM, et al.: How accurate is the reporting of obstetric haemorrhage 
in hospital discharge data? A validation study. Aust N Z J Obstet Gynaecol. 2008;48: 481-4. 
28 Roberts CL, Bell JC, Ford JB, et al.: Monitoring the quality of maternity care: how well are labour 
and delivery events reported in population health data? Paediatr Perinat Epidemiol. 2009;23: 
144-52. 
29 Taylor LK, Travis S, Pym M, et al.: How useful are hospital morbidity data for monitoring 
conditions occurring in the perinatal period? Aust N Z J Obstet Gynaecol. 2005;45: 36-41. 
30 MacNab YC, Qiu Z, Gustafson P, et al.: Hierarchical Bayes Analysis of Multilevel Health Services 
Data: A Canadian Neonatal Mortality Study. Health Services & Outcomes Research Methodology. 
2004;5: 5-26. 
31 Jakobsson M, Gissler M, Tapper AM: Risk factors for blood transfusion at delivery in Finland. 
Acta Obstet Gynecol Scand. 2013;92: 414-20. 
32 Ehrenthal DB, Chichester ML, Cole OS, et al.: Maternal risk factors for peripartum transfusion. J 
Womens Health. 2012;21: 792-7. 
33 Mhyre JMMD, Shilkrut AMD, Kuklina EVMDP, et al.: Massive Blood Transfusion During 
Hospitalization for Delivery in New York State, 1998-2007. Obstet Gynecol. 2013;122: 1288-94. 
34 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists: 
Management of Postpartum Haemorrhage (PPH). The Royal Australian and New Zealand College 
of Obstetricians and Gynaecologists,. 2011. 
35 Olive EC, Roberts CL, Algert CS, et al.: Placenta praevia: maternal morbidity and place of birth. 
Aust N Z J Obstet Gynaecol. 2005;45: 499-504. 
36 Sapere Research Group: Analysis of cost drivers and trends in the blood sector. Options to 
manage appropriate use of blood and blood products. Sapere Research Group,. 2011. 
37 So-Osman C, Cicilia J, Brand A, et al.: Triggers and appropriateness of red blood cell transfusions 
in the postpartum patient--a retrospective audit. Vox Sang. 2010;98: 65-9. 
38 Carson JL, Carless PA, Hebert PC: Transfusion thresholds and other strategies for guiding 
allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4: CD002042. 
39 Silverman JA, Barrett J, Callum JL: The appropriateness of red blood cell transfusions in the 
peripartum patient. Obstet Gynecol. 2004;104: 1000-4. 
40 Prick BW, Jansen AJG, Steegers EAP, et al.: Transfusion policy after severe postpartum 
haemorrhage: a randomised non-inferiority trial. BJOG. 2014: n/a-n/a. 
 
 
 
  
Table 1- Characteristics of women giving birth in NSW, 2008-2010. 
  Total RBC transfusion No RBC 
transfusion 
Total  279145 (100.0) 3914 (100.0) 275231 (100.0) 
Maternal age Under 20 9647 (3.5) 208 (5.3) 9439 (3.4) 
 20-34 202953 (72.7) 2746 (70.2) 200207 (72.7) 
 35+ 66545 (23.8) 960 (24.5) 65585 (23.8) 
Private patient Yes 95568 (34.2) 890 (22.7) 94678 (34.4) 
 No 183577 (65.8) 3024 (77.3) 180553 (65.6) 
Smoker Yes 33306 (11.9) 530 (13.5) 32776 (11.9) 
 No 245839 (88.1) 3384 (86.5) 242455 (88.1) 
Multiple birth Yes 4195 (1.5) 172 (4.4) 4023 (1.5) 
 No 274950 (98.5) 3742 (95.6) 271208 (98.5) 
Primiparous Yes 118830 (42.6) 2023 (51.7) 116807 (42.4) 
 No 160315 (57.4) 1891 (48.3) 158424 (57.6) 
Previous caesarean Yes 42493 (15.2) 601 (15.4) 41892 (15.2) 
 No 236652 (84.8) 3313 (84.6) 233339 (84.8) 
Gestational age 20-32 3946 (1.4) 194 (5.0) 3752 (1.4) 
 33-36 14116 (5.1) 388 (9.9) 13728 (5.0) 
 37+ 261083 (93.5) 3332 (85.1) 257751 (93.6) 
Mode of birth Normal vaginal 
deliverya 
162835 (58.3) 1641 (41.9) 161194 (58.6) 
 Caesarean 
section 
85044 (30.5) 1476 (37.7) 83568 (30.4) 
 Pre-labour 
caesarean 
49268 (17.6) 733 (18.7) 48535 (17.6) 
 Intrapartum 
Caesarean 
35773 (12.8) 742 (19.0) 35031 (12.7) 
 Instrumental 
Delivery 
32738 (11.7) 830 (21.2) 31908 (11.6) 
 Forceps  11247 (4.0) 408 (10.4) 10839 (3.9) 
 Vacuum 21491 (7.7) 422 (10.8) 21069 (7.7) 
Induction  76938 (27.6) 1329 (34.0) 75609 (27.5) 
Birthweight SGA 24271 (8.7) 237 (6.1) 24034 (8.7) 
 LGA 30741 (11.0) 636 (16.2) 30105 (10.9) 
Hospital type Tertiary 116951 (41.9) 2069 (52.9) 114882 (41.7) 
 Regional 58187 (20.8) 850 (21.7) 57337 (20.8) 
 Urban/other 35304 (12.6) 507 (13.0) 34797 (12.6) 
 Private 68703 (24.6) 488 (12.5) 68215 (24.8) 
Bleeding/platelet disorder 2329 (0.8) 2329 (0.8) 352 (9.0) 
awithout forceps or vacuum 
Table 2: Risk factors for red blood cell transfusion in the birth admission, with each model progressively 
adjusting for maternal factors, intervention factors and hospital factors, NSW, 2008-2010a. 
Variable Category Maternal Model 
OR (95%CI) 
Intervention Model 
OR (95%CI) 
Hospital Model OR 
(95%CI) 
Maternal age Under 20 1.27 (1.09,1.47) 1.40 (1.21,1.63) 1.40 (1.20,1.63) 
 20 to 34 1(ref) 1(ref) 1(ref) 
 35+ 1.14 (1.05,1.23) 1.13 (1.04,1.22) 1.12 (1.04,1.21) 
Private patient   0.69 (0.62,0.77) 0.69 (0.62,0.77) 0.81 (0.72,0.91) 
Australian born   0.82 (0.76,0.88) 0.85 (0.78,0.91) 0.84 (0.78,0.91) 
Blood/platelet disorder   12.5 (11.0,14.1) 11.8 (10.4,13.4) 11.8 (10.4,13.4) 
Primipara   1.57 (1.46,1.69) 1.17 (1.07,1.27) 1.16 (1.07,1.26) 
Previous caesarean   1.26 (1.14,1.40) 1.33 (1.18,1.50) 1.33 (1.19,1.50) 
Pregnancy hypertension   1.75 (1.60,1.92) 1.67 (1.52,1.84) 1.67 (1.52,1.83) 
Antepartum 
haemorrhage 
  2.49 (2.20,2.82) 2.34 (2.07,2.65) 2.34 (2.07,2.65) 
Placenta praevia   8.55 (7.47,9.78) 9.95 (8.56,11.6) 9.96 (8.56,11.6) 
Multiple birth   2.22 (1.87,2.63) 2.45 (2.05,2.91) 2.43 (2.04,2.90) 
LGA   1.69 (1.55,1.85) 1.66 (1.51,1.81) 1.65 (1.51,1.81) 
Gestation <32 weeks 1(ref) 1(ref) 1(ref) 
 33-36 0.73 (0.60,0.87) 0.71 (0.59,0.86) 0.72 (0.60,0.87) 
 37+ 0.54 (0.46,0.64) 0.50 (0.42,0.60) 0.51 (0.43,0.61) 
Regional analgesia     0.64 (0.59,0.70) 0.65 (0.59,0.71) 
Labour induction     1.39 (1.29,1.51) 1.39 (1.29,1.51) 
Augmented labour     1.42 (1.27,1.59) 1.42 (1.27,1.59) 
Episiotomy     1.50 (1.35,1.68) 1.51 (1.36,1.69) 
Mode of birth Normal vaginal 
delivery 
1(ref) 1(ref) 1(ref) 
 Instrumental   2.29 (2.05,2.57) 2.30 (2.05,2.57) 
 Intrapartum 
caesarean 
  2.14 (1.91,2.39) 2.13 (1.90,2.38) 
 Pre-labour 
caesarean 
  1.40 (1.22,1.60) 1.40 (1.22,1.60) 
Colocation Public (not 
colocated) 
1(ref) 1(ref) 1(ref) 
 Colocated Public     0.94 (0.78,1.13) 
 Colocated Private     0.47 (0.37,0.59) 
 Other private     0.54 (0.43,0.69) 
      
 Variance Unadjusted Maternal Intervention Hospital 
 0.17 (0.04) 0.12 (0.03) 0.11 (0.03) 0.05 (0.02) 
% reduction from 
unadjusted model 
 26.5 34.4 73.0 
a For full list of variables considered at each stage, see Appendix 1.
Table 3 Maternal and neonatal adjusted outcome rates, NSW, 2008-2010. 
 Apgar <7 at 5 mins n(%) Maternal morbidity n(%) Readmission rate n(%) 
Overall rate  5124 (1.84) 2042 (0.73) 7432 (2.66) 
Rate in women receiving transfusion  270 (6.90) 524 (13.39) 248 (6.34) 
Rate in women not receiving transfusion 4854 (1.76) 1518 (0.55) 7184 (2.61) 
Figure 1: Variation in hospital transfusion rates for red blood cell transfusion in the birth admission, NSW, 2008-2010.a 
 
a Dots represent hospital RBC transfusion rates, with 95% confidence intervals, and the horizontal line the average rate. 
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 Figure 2: Adjusted rates of maternal and neonatal morbidity and transfusion, NSW, 2008-2010. 
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